Protagonist Therapeutics Inc.
PTGX | NASDAQ
$145.89
+$0.91 (+0.63%)
Sep 22, 2026, 9:50 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 216.84M | 15.44M | n/a | 45.91M | 52.04M | 56.19M | 275.19M | 170.85M | 169.95M | 162.11M | -78.96M | -140.48M | -137.61M | -140.19M | -127.39M | -130.11M | -132.68M | -122.48M | -125.55M | -107.53M | -81.49M | -70.07M |
Depreciation & Amortization | 668K | 168K | n/a | 1.44M | 1.73M | 2.9M | 2.9M | 3.19M | 3.37M | 2.72M | 3.31M | 3.32M | 3.35M | 3.37M | 3.37M | 3.35M | 3.2M | 2.98M | 2.78M | 2.59M | 2.51M | 2.53M |
Stock-Based Compensation | 64.34M | 46.69M | 45.97M | 44.37M | 43.97M | 42M | 37.55M | 35.06M | 31.66M | 31.06M | 29.29M | 28.2M | 27.39M | 25.85M | 24.2M | 23.71M | 22.54M | 19.67M | 16.4M | 13.34M | 10.45M | 8.51M |
Other Working Capital | -2.62M | 2.09M | -22.93M | -21.4M | -49.94M | -53.89M | 31.55M | 26.98M | 33.37M | 45.57M | -6.68M | -2.7M | -13.35M | -16.23M | -13.71M | -9.25M | 8.85M | 9.15M | 5.18M | -505K | -23.07M | -29.37M |
Other Non-Cash Items | -133.23M | -133.39M | -134.51M | -7.4M | -8.66M | -9.56M | -8.88M | -7.46M | -5.63M | -4.35M | -4.38M | -3.94M | -3.02M | -1.97M | -549K | 874K | 1.46M | 1.84M | 1.83M | 1.65M | 1.24M | 699K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 34K | 26K | 1.26M |
Change in Working Capital | -66.36M | -45.55M | 146.21M | -18.85M | -49.54M | 245.41M | -122.61M | 28.65M | 32.19M | -254.86M | -19.51M | -5.93M | -7.52M | 8.12M | -7.77M | -1.27M | -1.23M | -18.79M | -3.31M | -9.87M | -20.35M | -28.32M |
Operating Cash Flow | 82.25M | -116.64M | 57.67M | 65.47M | 39.54M | 336.94M | 184.15M | 230.29M | 231.54M | -63.32M | -70.24M | -118.83M | -117.42M | -104.82M | -108.14M | -103.44M | -106.71M | -116.78M | -107.87M | -99.79M | -87.61M | -85.39M |
Capital Expenditures | 760K | 330K | n/a | -1.76M | -2.44M | -1.66M | -1.36M | -1.06M | -693K | -841K | -609K | -660K | -418K | -532K | -795K | -921K | -1.02M | -1.23M | -1.1M | -1.03M | -840K | -473K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25.94M | -35.77M | -35.77M | -35.77M | -9.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | 8.58M | 145.07M | n/a | -556.72M | -662.27M | -770.07M | -621.7M | -605.26M | -397.55M | -228.66M | -191.05M | -173.67M | -146.88M | -187.1M | -214.87M | -164.97M | -225.25M | -255.22M | -286.59M | -388.33M | -376.73M | -346.35M |
Sales Maturities Of Investments | 209.6M | 39.89M | -4K | 451.61M | 407.69M | 371.77M | 323.57M | 254.28M | 241.35M | 186.48M | 152.4M | 200.3M | 244.09M | 293.4M | 307.14M | 281.29M | 239.69M | 242.91M | 271.83M | 271.23M | 250.03M | 206.33M |
Other Investing Acitivies | -49.32M | -49.33M | -49.33M | -5K | -5K | n/a | n/a | n/a | n/a | 25.94M | 35.77M | 35.77M | 35.77M | 9.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 169.61M | 135.96M | -49.33M | -106.87M | -257.03M | -399.96M | -299.48M | -352.05M | -156.89M | -43.01M | -39.26M | 25.96M | 96.8M | 105.77M | 91.47M | 115.4M | 13.42M | -13.54M | -15.86M | -118.13M | -127.54M | -140.49M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.53M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -479K | -479K | -479K | -479K | -600K | -81K | 35.31M | 35.62M | 38.38M | 37.86M | 2.46M | 2.16M | 2.37M | 4.71M | 4.71M | 6.11M | 3.55M | 1.52M | 3.01M | 1.62M |
Financial Cash Flow | 64.99M | 34.8M | 22.86M | 24.06M | 30.45M | 30.1M | 25.85M | 22.35M | 45.61M | 151.21M | 170.48M | 170.5M | 135.87M | 28.38M | 18.84M | 20.46M | 21.16M | 145.87M | 129.92M | 254.73M | 261.02M | 248.21M |
Net Cash Flow | 316.86M | 54.12M | 31.21M | -17.34M | -187.04M | -32.92M | -89.48M | -99.41M | 120.26M | 44.88M | 60.98M | 77.71M | 115.15M | 29.21M | 2.08M | 32.27M | -72.18M | 15.48M | 6.3M | 36.91M | 46.16M | 22.78M |
Free Cash Flow | 83.01M | -116.31M | 57.67M | 63.71M | 37.1M | 335.29M | 182.8M | 229.23M | 230.85M | -64.16M | -70.85M | -119.49M | -117.84M | -105.35M | -108.93M | -104.36M | -107.73M | -118.01M | -108.97M | -100.82M | -88.45M | -85.87M |
Adj. Free Cash Flow | 18.68M | -163M | 11.7M | 19.35M | -6.87M | 293.28M | 145.24M | 194.16M | 199.19M | -95.22M | -100.14M | -147.7M | -145.23M | -131.2M | -133.13M | -128.08M | -130.27M | -137.68M | -125.36M | -114.16M | -98.9M | -94.38M |
Maintenance CapEx | 763.08K | 448.01K | 118.01K | -1.33M | -1.7M | -1M | -458.97K | -458.97K | -404K | -580K | -590K | -660K | -418K | -532K | -522K | -452K | -555K | -765K | -765K | -765K | -500K | n/a |
Growth CapEx | -3.08K | -118.01K | -118.01K | -428.01K | -740.96K | -654.03K | -896.03K | -605.03K | -289K | -261K | -19K | n/a | n/a | n/a | -273K | -469K | -469K | -469K | -336K | -265K | -340K | -473K |
Owner Earnings | 83.02M | -116.19M | 57.79M | 64.14M | 37.84M | 335.94M | 183.69M | 229.83M | 231.14M | -63.9M | -70.83M | -119.49M | -117.84M | -105.35M | -108.66M | -103.89M | -107.27M | -117.54M | -108.63M | -100.56M | -88.11M | -85.39M |
Add to Watchlist
Select watchlists to add or remove PTGX